<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02501070</url>
  </required_header>
  <id_info>
    <org_study_id>D5130C00091</org_study_id>
    <nct_id>NCT02501070</nct_id>
  </id_info>
  <brief_title>Impact on Public HEalth of a Network in Acute Myocardial Infarction Care</brief_title>
  <acronym>iPHENAMIC</acronym>
  <official_title>Impact of Implantation of PROGALIAM Network (Galician Program of Care in Acute Myocardial Infarction) in Cardiovascular Health in the Northern Area of Galicia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complexo Hospitalario Universitario de A Coruña</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Lucus Augusti</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Arquitecto Marcide</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Complexo Hospitalario Universitario de A Coruña</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter retrospective observational study with STEMI (ST Elevation Myocardial
      Infarction) patients who have been treated in the northern Galician Hospitals. The study
      tries to verify if the implantation of the PROGALIAM (Galician Assistance Program Acute
      Myocardial Infarction) has supposed a progress in the quality and expectancy of life of AMI
      patients in the north area of Galicia.

      The study will recruit STEMI patients according to the third consensus definition of
      myocardial infarction type I.

      It will include all patients who meet these criteria regardless of other demographic or
      clinical circumstances. There is not exclusion criteria defined for this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Study Hypothesis This study tries to verify if the implantation of the PROGALIAM has
           supposed a progress in the quality and expectancy of life of AMI patients in the north
           area of Galicia.

        -  Objectives.

      The study presents the following objectives:

      Primary Objectives:

      To compare morbidity rates between pre and post-PROGALIAM periods in major adverse cardiac
      events. The outcome to study is a composite of death, reinfarction, heart failure and major
      bleeding at 30 days, one year and long term follow-up.

      Secondary Objectives To compare Pre and post PROGALIAM periods regarding;

      1. Overall mortality at 30 days, one year and long term follow up. 2. Reinfarction at 30
      days, one year and long term follow up. 3. Heart failure incidence at 30 days, one year and
      long term follow up 4. Hospital major bleeding and at 30 days. 5. Hospital Vascular
      complications and at 30 days. 6. Heart failure functional Class at 30 days, one year and long
      term follow up.

        -  Study Design This is a multicenter retrospective observational study with STEMI patients
           who have been treated in the northern Galician Hospitals.

             1. Pre-PROGALIAM period: January 2001- May 2005

             2. Post-PROGALIAM period: June 2005- December 2011

        -  Rational for Sample size Sample size will be constituted by all STEMI cases occurred in
           both timeframes described above.

      According to data obtained in MASCARA register where approximately 38% of ACS patients
      present ST segment elevation, the estimated sample size would therefore be about 6100
      patients.

      *Inclusion, Exclusion Criteria and rational The study will recruit STEMI patients according
      to the third consensus definition of myocardial infarction type I. It was recently published.

      It will include all patients who meet these criteria regardless of other demographic or
      clinical circumstances. There is not exclusion criteria defined for this population.

      *Statistical analysis Categorical variables will be presented in percentage, calculated from
      the whole valid information. The CI will be of 95 %. Quantitative variables will be presented
      as mean ± standard deviation or median (interquartile range) according to a normal underlying
      distribution or not. Initially a univariate analysis will be done.

      The comparison of quantitative variables means will be done by student´s t-test in case of
      normality or by nonparametric tests in the opposite case. Categorical variables will be
      analyzed by the Chi square test. Survival will be analyzed by Kaplan-Meier curves. The
      comparison between pre and post PROGALIAM curves will be done by a log-rank test. A p &lt;0.05
      will be considered statistically significant for two-tailed tests.

      Also there are plans to carry out a multivariate analysis. There will be a quantification of
      the adjusted effect on mortality due to the introduction of PROGALIAM by a Cox Proportional
      Hazards model. It will be defined the best model to predict this adjusted event by
      independent variables which can demonstrate an impact on death outcome in the univariate
      model and by those independent variables in which significant differences are observed
      between the pre and post PROGALIAM population. The investigators will verify if the
      implementation of the PROGALIAM is an independent predictor of survival and the impact that
      generates in the model.

      A p &lt;0.05 result will be considered statistically significant in a two-tailed test.

      To carry out these analyses it will be necessary to have statistical software like SPSS
      and/or SAS.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days</time_frame>
    <description>A composite of total death and cardiovascular death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACE Death Pre vs Post PROGALIAM implantation (Mayor Adverse Cardiovascular Events) (measured from medical records)</measure>
    <time_frame>30 days</time_frame>
    <description>A composite of death, reinfarction, heart failure and bleeding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>one year</time_frame>
    <description>A composite of total death and cardiovascular death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MACE Death Pre vs Post PROGALIAM implantation (Mayor Adverse Cardiovascular Events) (measured from medical records)</measure>
    <time_frame>one year</time_frame>
    <description>A composite of death, reinfarction, heart failure and bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall mortality Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days, One year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinfarction Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days, one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Mayor bleeding Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular Complications Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart failure Death Pre vs Post PROGALIAM implantation (measured from medical records)</measure>
    <time_frame>30 days, one year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">5937</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Pre-PROGALIAM</arm_group_label>
    <description>Patients treated for myocardial infarction before the implementation of the network for acute myocardial infarction care (2001 to 2005).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PROGALIAM</arm_group_label>
    <description>Patients treated for myocardial infarction after the implementation of the network for acute myocardial infarction care (2005 to 2011).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study will gather patients with STEMI (ST segment Elevation Myocardial Infarction)
        according to the third consensus definition of myocardial infarction treated at Northern
        Galician Network of Acute Myocardial Infarction.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients suffering STEMI (ST segment Elevation Myocardial Infarction) treated at
             Northern Galician Network of Acute Myocardial Infarction

        Exclusion Criteria:

          -  No exclusion Criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo Aldama, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario de A Coruña</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Melisa Santás, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Lucus Augusti</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Lopez, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Arquitecto Marcide</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario de A Coruña</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, Betriu A, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, Kristensen SD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, Radovanovic D, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, Zeymer U; European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010 Apr;31(8):943-57. doi: 10.1093/eurheartj/ehp492. Epub 2009 Nov 19.</citation>
    <PMID>19933242</PMID>
  </results_reference>
  <results_reference>
    <citation>Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M; CZECH investigators. The incidence, treatment strategies and outcomes of acute coronary syndromes in the &quot;reperfusion network&quot; of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol. 2007 Jul 10;119(2):212-9. Epub 2007 Apr 18.</citation>
    <PMID>17442424</PMID>
  </results_reference>
  <results_reference>
    <citation>McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011 Jan;124(1):40-7. doi: 10.1016/j.amjmed.2010.07.023.</citation>
    <PMID>21187184</PMID>
  </results_reference>
  <results_reference>
    <citation>Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15. Erratum in: Circulation. 2012 Jun 5;125(22):e1002.</citation>
    <PMID>22179539</PMID>
  </results_reference>
  <results_reference>
    <citation>Mandelzweig L, Battler A, Boyko V, Bueno H, Danchin N, Filippatos G, Gitt A, Hasdai D, Hasin Y, Marrugat J, Van de Werf F, Wallentin L, Behar S; Euro Heart Survey Investigators. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006 Oct;27(19):2285-93. Epub 2006 Aug 14.</citation>
    <PMID>16908490</PMID>
  </results_reference>
  <results_reference>
    <citation>Jernberg T, Johanson P, Held C, Svennblad B, Lindbäck J, Wallentin L; SWEDEHEART/RIKS-HIA. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011 Apr 27;305(16):1677-84. doi: 10.1001/jama.2011.522.</citation>
    <PMID>21521849</PMID>
  </results_reference>
  <results_reference>
    <citation>Marrugat J, Elosua R, Martí H. [Epidemiology of ischaemic heart disease in Spain: estimation of the number of cases and trends from 1997 to 2005]. Rev Esp Cardiol. 2002 Apr;55(4):337-46. Spanish.</citation>
    <PMID>11975899</PMID>
  </results_reference>
  <results_reference>
    <citation>Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.</citation>
    <PMID>22922416</PMID>
  </results_reference>
  <results_reference>
    <citation>Mamas MA, Ratib K, Routledge H, Fath-Ordoubadi F, Neyses L, Louvard Y, Fraser DG, Nolan J. Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials. Heart. 2012 Feb;98(4):303-11. doi: 10.1136/heartjnl-2011-300558. Epub 2011 Dec 6. Review.</citation>
    <PMID>22147900</PMID>
  </results_reference>
  <results_reference>
    <citation>Estévez-Loureiro R, Calviño-Santos R, Vázquez JM, Barge-Caballero E, Salgado-Fernández J, Piñeiro M, Freire-Tellado M, Varela-Portas J, Martínez L, Gómez S, Rodríguez JA, Vázquez N, Castro-Beiras A. Safety and feasibility of returning patients early to their originating centers after transfer for primary percutaneous coronary intervention. Rev Esp Cardiol. 2009 Dec;62(12):1356-64.</citation>
    <PMID>20038401</PMID>
  </results_reference>
  <results_reference>
    <citation>Barge-Caballero E, Vázquez-Rodríguez JM, Estévez-Loureiro R, Calviño-Santos R, Salgado-Fernández J, Aldama-López G, Piñón-Esteban P, Flores-Ríos X, Campo-Pérez R, Rodríguez-Fernández JÁ, Lombán-Villanueva JA, Mesías-Prego A, Gutiérrez-Cortés JM, González-Juanatey C, Portela C, Iglesias-Vázquez A, Varela-Portas Mariño J, Vázquez-González N, Castro-Beiras A. Primary angioplasty in Northern Galicia: care changes and results following implementation of the PROGALIAM protocol. Rev Esp Cardiol (Engl Ed). 2012 Apr;65(4):341-9. doi: 10.1016/j.recesp.2011.11.003. Epub 2012 Feb 10.</citation>
    <PMID>22325936</PMID>
  </results_reference>
  <results_reference>
    <citation>Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16;126(16):2020-35. doi: 10.1161/CIR.0b013e31826e1058. Epub 2012 Aug 24.</citation>
    <PMID>22923432</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferreira-González I, Permanyer-Miralda G, Marrugat J, Heras M, Cuñat J, Civeira E, Arós F, Rodríguez JJ, Sánchez PL, Bueno H; MASCARA study research team. MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) study. General findings. Rev Esp Cardiol. 2008 Aug;61(8):803-16. English, Spanish. Erratum in: Rev Esp Cardiol. 2008 Nov;61(11):1228.</citation>
    <PMID>18684363</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2015</study_first_submitted>
  <study_first_submitted_qc>July 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2015</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Complexo Hospitalario Universitario de A Coruña</investigator_affiliation>
    <investigator_full_name>Guillermo Aldama</investigator_full_name>
    <investigator_title>Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>Stent</keyword>
  <keyword>Community Networks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

